EKSO BIONICS (EKSO) Financial Statements


EKSO BIONICS Financial Overview

EKSO BIONICS's market cap is currently ―. The company's EPS TTM is $-0.968; its P/E ratio is -1.26; EKSO BIONICS is scheduled to report earnings on July 25, 2024, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 4.85M$ 4.61M$ 4.70M-$ 3.55M
Gross Profit$ 2.37M$ 2.46M$ 2.25M$ -2.12M$ 1.68M
EBIT$ -3.15M$ -3.30M$ -4.17M$ -4.26M$ -3.11M
EBITDA$ -2.47M$ -2.88M$ -3.74M$ -3.85M$ -2.86M
Net Income Common Stockholders$ -3.21M$ -3.37M$ -4.23M$ -4.39M$ -3.18M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.64M$ 9.94M$ 13.31M$ 16.28M$ 20.52M
Total Assets$ 28.92M$ 31.18M$ 33.99M$ 37.10M$ 40.90M
Total Debt$ 7.17M$ 7.48M$ 7.50M$ 7.50M$ 7.50M
Net Debt$ -1.47M$ -2.45M$ -5.80M$ -8.77M$ -13.02M
Total Liabilities$ 16.31M$ 15.93M$ 16.18M$ 15.82M$ 15.46M
Stockholders Equity$ 12.61M$ 15.26M$ 17.81M$ 21.28M$ 25.44M
Cash Flow-
Free Cash Flow$ -1.63M$ -3.37M$ -2.96M$ -4.26M$ -3.70M
Operating Cash Flow$ -1.58M$ -3.35M$ -2.90M$ -4.21M$ -3.64M
Investing Cash Flow$ -43.00K$ -17.00K$ -55.00K$ -42.00K$ -5.03M
Financing Cash Flow$ 348.00K---$ 0.00
Currency in USD

EKSO BIONICS Earnings and Revenue History

EKSO BIONICS Debt to Assets


EKSO BIONICS Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis